177 related articles for article (PubMed ID: 22293929)
41. Chronic inflammatory demyelinating polyneuropathy.
Said G
Neuromuscul Disord; 2006 May; 16(5):293-303. PubMed ID: 16631367
[TBL] [Abstract][Full Text] [Related]
42. Fatigue as the presenting symptom of chronic inflammatory demyelinating polyneuropathy.
Bissay V; Flamez A; Schmedding E; Ebinger G
Muscle Nerve; 2008 Dec; 38(6):1653-7. PubMed ID: 19012289
[TBL] [Abstract][Full Text] [Related]
43. The value of sensory electrophysiology in chronic inflammatory demyelinating polyneuropathy.
Rajabally YA; Narasimhan M
Clin Neurophysiol; 2007 Sep; 118(9):1999-2004. PubMed ID: 17644033
[TBL] [Abstract][Full Text] [Related]
44. Chronic dysimmune neuropathy. A subclassification based upon the clinical features of 102 patients.
Busby M; Donaghy M
J Neurol; 2003 Jun; 250(6):714-24. PubMed ID: 12796835
[TBL] [Abstract][Full Text] [Related]
45. Blink reflex alterations in diabetic patients with or without polyneuropathy.
Guney F; Demir O; Gonen MS
Int J Neurosci; 2008 Sep; 118(9):1287-98. PubMed ID: 18698511
[TBL] [Abstract][Full Text] [Related]
46. N(epsilon)-Carboxymethyllysine in diabetic and non-diabetic polyneuropathies.
Haslbeck KM; Schleicher ED; Friess U; Kirchner A; Neundörfer B; Heuss D
Acta Neuropathol; 2002 Jul; 104(1):45-52. PubMed ID: 12070663
[TBL] [Abstract][Full Text] [Related]
47. Diabetic neuropathy differs in type 1 and type 2 diabetes.
Sima AA; Kamiya H
Ann N Y Acad Sci; 2006 Nov; 1084():235-49. PubMed ID: 17151305
[TBL] [Abstract][Full Text] [Related]
48. Derivation and validation of diagnostic criteria for chronic inflammatory demyelinating polyneuropathy.
Koski CL; Baumgarten M; Magder LS; Barohn RJ; Goldstein J; Graves M; Gorson K; Hahn AF; Hughes RA; Katz J; Lewis RA; Parry GJ; van Doorn P; Cornblath DR
J Neurol Sci; 2009 Feb; 277(1-2):1-8. PubMed ID: 19091330
[TBL] [Abstract][Full Text] [Related]
49. Prevalence and impact on quality of life of peripheral neuropathy with or without neuropathic pain in type 1 and type 2 diabetic patients attending hospital outpatients clinics.
Van Acker K; Bouhassira D; De Bacquer D; Weiss S; Matthys K; Raemen H; Mathieu C; Colin IM
Diabetes Metab; 2009 Jun; 35(3):206-13. PubMed ID: 19297223
[TBL] [Abstract][Full Text] [Related]
50. Atypical childhood chronic inflammatory demyelinating polyneuropathy.
Mohamed AR; Rodriguez-Casero MV; Ryan MM
Muscle Nerve; 2010 Aug; 42(2):293-5. PubMed ID: 20589891
[TBL] [Abstract][Full Text] [Related]
51. Chronic inflammatory demyelinating polyneuropathy in a child: clinical-spinal MR imaging correlation.
Likasitwattanakul S; Visrutaratna P
Singapore Med J; 2004 Nov; 45(11):536-7. PubMed ID: 15510327
[TBL] [Abstract][Full Text] [Related]
52. Chronic inflammatory demyelinating polyradiculoneuropathy in two children with type 1 diabetes mellitus.
Fudge E; Carol J; She JX; Dosch M; Atkinson M; Muir A
Pediatr Diabetes; 2005 Dec; 6(4):244-8. PubMed ID: 16390395
[TBL] [Abstract][Full Text] [Related]
53. AL amyloid neuropathy mimicking a chronic inflammatory demyelinating polyneuropathy.
Luigetti M; Papacci M; Bartoletti S; Marcaccio A; Romano A; Sabatelli M
Amyloid; 2012 Mar; 19(1):53-5. PubMed ID: 22292918
[No Abstract] [Full Text] [Related]
54. [Diabetes mellitus and autoimmune neuropathy].
Deguchi T; Nishio Y; Takashima H
Brain Nerve; 2014 Feb; 66(2):135-47. PubMed ID: 24523312
[TBL] [Abstract][Full Text] [Related]
55. Motor nerve decline does not underlie muscle weakness in type 2 diabetic neuropathy.
Ijzerman TH; Schaper NC; Melai T; Blijham P; Meijer K; Willems PJ; Savelberg HH
Muscle Nerve; 2011 Aug; 44(2):241-5. PubMed ID: 21755507
[TBL] [Abstract][Full Text] [Related]
56. [New trends in neuropathy practice: clinical approach to CIDP].
Baba M
Rinsho Shinkeigaku; 2001 Dec; 41(12):1210-3. PubMed ID: 12235840
[TBL] [Abstract][Full Text] [Related]
57. Pain as the presenting symptom of chronic inflammatory demyelinating polyradiculoneuropathy (CIDP).
Boukhris S; Magy L; Khalil M; Sindou P; Vallat JM
J Neurol Sci; 2007 Mar; 254(1-2):33-8. PubMed ID: 17286985
[TBL] [Abstract][Full Text] [Related]
58. [Incidence of diabetic neuropathy which fulfills electrophysiologic criteria of CIDP].
Miyasaki H; Hasegawa O; Mori I; Matsumoto S; Arita T
No To Shinkei; 1999 May; 51(5):415-8. PubMed ID: 10396747
[TBL] [Abstract][Full Text] [Related]
59. [Toronto clinical scoring system in diabetic peripheral neuropathy].
Liu F; Mao JP; Yan X
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Dec; 33(12):1137-41. PubMed ID: 19141982
[TBL] [Abstract][Full Text] [Related]
60. Patients with chronic inflammatory demyelinating polyneuropathy initially diagnosed as Guillain-Barré syndrome.
Odaka M; Yuki N; Hirata K
J Neurol; 2003 Aug; 250(8):913-6. PubMed ID: 12928908
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
